当前位置：
X-MOL 学术
›
Human Psychopharmacology: Clinical and Experimental
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls.
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2020-05-25 , DOI: 10.1002/hup.2732 Eric M Pearlman 1 , Darren Wilbraham 1 , Ellen B Dennehy 1, 2 , Paul H Berg 1 , Max Tsai 1 , Erin G Doty 1 , Gary G Kay 3
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2020-05-25 , DOI: 10.1002/hup.2732 Eric M Pearlman 1 , Darren Wilbraham 1 , Ellen B Dennehy 1, 2 , Paul H Berg 1 , Max Tsai 1 , Erin G Doty 1 , Gary G Kay 3
Affiliation
To evaluate the impact of lasmiditan, an oral, centrally‐penetrant, selective serotonin 1F (5‐HT1F) receptor agonist developed for the acute treatment of migraine, on simulated driving.
中文翻译：
lasmiditan 对模拟驾驶表现的影响：两项随机、盲法、安慰剂和活性对照交叉研究的结果。
旨在评估 lasmiditan（一种口服、中枢渗透性、选择性血清素 1F (5-HT 1F ) 受体激动剂，为急性偏头痛治疗而开发）对模拟驾驶的影响。
更新日期：2020-05-25
中文翻译：
lasmiditan 对模拟驾驶表现的影响：两项随机、盲法、安慰剂和活性对照交叉研究的结果。
旨在评估 lasmiditan（一种口服、中枢渗透性、选择性血清素 1F (5-HT 1F ) 受体激动剂，为急性偏头痛治疗而开发）对模拟驾驶的影响。
京公网安备 11010802027423号